BIGLIARDI, MARTINA
BIGLIARDI, MARTINA
Flow biocatalysis: a pathway to sustainable innovation
2025 M. Bigliardi, M.L. Contente
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
2025 L. Castagnoli, A. Franceschini, V. Cancila, M. Dugo, M. Bigliardi, C. Chiodoni, P. Toneguzzo, V. Regondi, P.A. Corsetto, F. Pietrantonio, S. Mazzucchelli, F. Corsi, A. Belfiore, A. Vingiani, G. Pruneri, F. Ligorio, M.P. Colombo, E. Tagliabue, C. Tripodo, C. Vernieri, T. Triulzi, S.M. Pupa
Spinning Green: Lipase-Catalyzed Synthesis of Bioactive Fatty Acid Amides from Renewable Lipid Feedstocks in a Rotating Bed Reactor
2025 M. Bigliardi, S. Donzella, D. Dăescu, A. Pellis, L. Tamborini, A. Pinto, M.L. Contente
Cooperative Enhancement of Aldoxime Dehydratase Stability through Whole‐Cell Immobilization and Flow Reactor Integration
2025 L. Nespoli, S. Donzella, M. Bigliardi, M.L. Contente, R.P.D.S. Oliveira, D. Romano, F. Molinari
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer
2025 L. Castagnoli, F. Bonì, M. Bigliardi, P. Toneguzzo, P.A. Corsetto, G. Galasso, A. Franceschini, P. Cocomazzi, V. Regondi, C. Capuzzoni, A.M. Rizzo, F. Ligorio, C. Vernieri, P. Seneci, D. Arosio, E. Tagliabue, E. Mastrangelo, M. Milani, S.M. Pupa
Multiple organs exhibit exacerbated cachexia in male mice with colon cancer than females
2025 M. Barone, M. Lunardi, A.D. Re Cecconi, F. Palo, D. Olivari, F. Cerruti, P. Cascio, L. Castagnoli, M. Bigliardi, L. Pasetto, V. Bonetto, M. Galbiati, A. Poletti, R. Piccirillo